949 related articles for article (PubMed ID: 14742768)
1. Beta-blocker underuse in secondary prevention of myocardial infarction.
Everly MJ; Heaton PC; Cluxton RJ
Ann Pharmacother; 2004 Feb; 38(2):286-93. PubMed ID: 14742768
[TBL] [Abstract][Full Text] [Related]
2. Post-myocardial infarction beta-blocker therapy: the bradycardia conundrum. Rationale and design for the Pacemaker & beta-blocker therapy post-MI (PACE-MI) trial.
Goldberger JJ; Bonow RO; Cuffe M; Dyer A; Greenland P; Rosenberg Y; O'Rourke R; Shah PK; Smith S
Am Heart J; 2008 Mar; 155(3):455-64. PubMed ID: 18294477
[TBL] [Abstract][Full Text] [Related]
3. Use and adherence to beta-blockers for secondary prevention of myocardial infarction: who is not getting the treatment?
Wei L; Flynn R; Murray GD; MacDonald TM
Pharmacoepidemiol Drug Saf; 2004 Nov; 13(11):761-6. PubMed ID: 15386713
[TBL] [Abstract][Full Text] [Related]
4. Reappraisal of beta-blocker therapy in the acute and chronic post-myocardial infarction period.
Borrello F; Beahan M; Klein L; Gheorghiade M
Rev Cardiovasc Med; 2003; 4 Suppl 3():S13-24. PubMed ID: 14564230
[TBL] [Abstract][Full Text] [Related]
5. Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers.
Brooks TW; Creekmore FM; Young DC; Asche CV; Oberg B; Samuelson WM
Pharmacotherapy; 2007 May; 27(5):684-90. PubMed ID: 17461703
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the effect on patient outcomes of appropriate and inappropriate use of beta-blockers as secondary prevention after myocardial infarction in a medicaid population.
Fernandes AW; Madhavan SS; Amonkar MM
Clin Ther; 2005 May; 27(5):630-45. PubMed ID: 15978313
[TBL] [Abstract][Full Text] [Related]
7. Does tight heart rate control improve beta-blocker efficacy? An updated analysis of the noncardiac surgical randomized trials.
Beattie WS; Wijeysundera DN; Karkouti K; McCluskey S; Tait G
Anesth Analg; 2008 Apr; 106(4):1039-48, table of contents. PubMed ID: 18349171
[TBL] [Abstract][Full Text] [Related]
8. Nebivolol: a third-generation beta-blocker for hypertension.
Cheng JW
Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
[TBL] [Abstract][Full Text] [Related]
9. Beta-adrenergic antagonists in hypertension: a review of the evidence.
Warmack TS; Estes MA; Heldenbrand S; Franks AM
Ann Pharmacother; 2009 Dec; 43(12):2031-43. PubMed ID: 19934392
[TBL] [Abstract][Full Text] [Related]
10. Benefits of inpatient initiation of beta-blockers.
Ventura HO
Am Heart J; 2004 Dec; 148(6):944-50. PubMed ID: 15632876
[TBL] [Abstract][Full Text] [Related]
11. Benefits of non-selective versus cardioselective beta-blockers in acute myocardial infarction in hypertensive patients.
Hansen O; Johansson BW
J Hypertens Suppl; 1993 Jun; 11(4):S55-60. PubMed ID: 8104242
[TBL] [Abstract][Full Text] [Related]
12. Drug therapy for prevention of recurrent myocardial infarction.
van der Elst ME; Buurma H; Bouvy ML; de Boer A
Ann Pharmacother; 2003 Oct; 37(10):1465-77. PubMed ID: 14519050
[TBL] [Abstract][Full Text] [Related]
13. Mortality and reinfarction among patients using different beta-blockers for secondary prevention after a myocardial infarction.
Andersen SS; Hansen ML; Gislason GH; Folke F; Schramm TK; Fosbøl E; Sørensen R; Rasmussen S; Abildstrøm SZ; Madsen M; Køber L; Torp-Pedersen C
Cardiology; 2009; 112(2):144-50. PubMed ID: 18612201
[TBL] [Abstract][Full Text] [Related]
14. Beta-adrenergic blocking agents in the treatment of patients after a myocardial infarction.
Goldstein S
Henry Ford Hosp Med J; 1991; 39(3-4):200-5. PubMed ID: 1687143
[TBL] [Abstract][Full Text] [Related]
15. The Beta-Blocker Pooling Project (BBPP): subgroup findings from randomized trials in post infarction patients. The Beta-Blocker Pooling Project Research Group.
Eur Heart J; 1988 Jan; 9(1):8-16. PubMed ID: 2894312
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin receptor blockers versus ACE inhibitors: prevention of death and myocardial infarction in high-risk populations.
Epstein BJ; Gums JG
Ann Pharmacother; 2005 Mar; 39(3):470-80. PubMed ID: 15701766
[TBL] [Abstract][Full Text] [Related]
17. Primary and secondary prevention of myocardial infarction and strokes: an update of randomly allocated, controlled trials.
Yusuf S; Lessem J; Jha P; Lonn E
J Hypertens Suppl; 1993 Jun; 11(4):S61-73. PubMed ID: 8104243
[TBL] [Abstract][Full Text] [Related]
18. Effects of beta-blockers on glucose and lipid metabolism.
Fonseca VA
Curr Med Res Opin; 2010 Mar; 26(3):615-29. PubMed ID: 20067434
[TBL] [Abstract][Full Text] [Related]
19. [Beta-blocker in secondary prevention of cardiovascular disease].
Sauer G
Z Kardiol; 2003 Jan; 92(1):24-30. PubMed ID: 12545298
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of perioperative beta-blockade in patients undergoing noncardiac surgery: a meta-analysis.
Talati R; Reinhart KM; White CM; Phung OJ; Sedrakyan A; Kluger J; Coleman CI
Ann Pharmacother; 2009 Jul; 43(7):1181-8. PubMed ID: 19531697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
